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trol, and patient utility. METHODS: 84 asthmatic sub-
jects completed the AQLQ. Self-rated asthma severity
and control was measured on a 5-point Likert scale and
utilities were measured using a rating scale. SES was de-
fined based on receipt of social assistance. Correlations
between AQLQ scores and each other variable were mea-
sured using Spearman’s Rank correlation coefficient (rS).
Differences in rs between social classes (rsdiff) were ana-
lyzed using Fisher’s r to z transformation (2-tailed). RE-
SULTS: 38 (45%) patients were receiving social assis-
tance. In the entire sample, there was significant
correlation (p  0.05) between all AQLQ scores (symp-
toms, activity, emotion, environment, and global), self-
rated asthma severity (rS  0.21–0.38), control (rS 
0.21–0.38), and utilities. Symptom, activity, and global
AQLQ scores were correlated strongly with utility (rS 
0.53–0.54; p  0.0001) and moderately with environ-
ment and emotion scores (rS  0.38;p  0.002). How-
ever, AQLQ scores were consistently more strongly cor-
related with self-assessed severity and control in lower
SES patients. Although rS diff ranged from 0.07 to 0.55
(mean  0.27), only the most extreme difference was sig-
nificant (activity score and control  rS diff  0.55; p 
0.01). Conversely, rS between all AQLQ scores and utility
were consistently lower (mean rS diff  0.18; range 0.9–
0.23) in patients on social assistance, although not signif-
icantly. CONCLUSIONS: Correlations between AQLQ
scores and utility were consistently lower in lower SES
subjects, suggesting that AQLQ may be a better measure
of overall health in higher SES patients. Conversely,
AQLQ scores correlated more strongly with self-rated
asthma severity and control in lower SES subjects. Al-
though most differences were not significant despite their
magnitude, this is likely due to a recognized lack of
power of the Fisher’s r to z transformation test.
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OBJECTIVE: The St. George’s Respiratory Question-
naire (SGRQ) has been validated and widely used in as-
sessing health-related quality (HRQL) of life among
Chronic Obstructive Pulmonary Disease (COPD) patients
but it is complicated to score and can be a burden on re-
spondents when there is limited time. A shorter and more
concise instrument, Airways Questionnaire (AQ30), was
developed to measure Quality of Life (QoL) of patients
with obstructive airways. The AQ20 contains 20 items
on the AQ30. The purpose of this study was to evaluate
and compare the responsiveness of the AQ20 and the
SGRQ questionnaires to measure health-related quality
of life of patients with COPD. STUDY DESIGN: Re-
sponses from a survey of 1,000 COPD patients partici-
pating in a pilot health management program were in-
cluded in the analysis. A total of 181 COPD patients
completed the AQ20 and the SGRQ. Spearman’s Rank
correlation was used to determine if the AQ20 and the
SGRQ scores for symptoms, activity and impact and the
overall score were correlated. A high correlation suggests
that both surveys are capturing the same information.
RESULTS: Scores for both AQ20 and the SGRQ were
available for 181 cases. The correlation between the
AQ20 and the symptoms component scores was 0.67
(p  0.05). Correlation between the AQ20 and the activ-
ity component was 0.69 (p  0.05) and the AQ20 and
the impact component was 0.79 (p  0.05). The correla-
tion between the AQ20 and the total SGRQ was 0.82
(p  0.05). CONCLUSION: The AQ20 appears to have
similar properties and responsiveness that are similar to
complex questionnaires such as the SGRQ. Because it is
short and easy to administer the AQ20 may be useful in
settings with limited time for HRQL assessments.
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OBJECTIVES: Morbidity due to respiratory infections
leads to significant adverse societal and economic conse-
quences. This study investigates the extent to which treat-
ment for respiratory infections imposes a financial bur-
den on an employer, and documents variations in employer
payments between specific respiratory infections. METH-
ODS: The data source is a rich administrative claims da-
tabase for a national, Fortune 100 manufacturer. It in-
cludes 1997 medical, pharmaceutical, and disability claims
for employees, spouses, dependents, and retirees (n 
100,000) under age 65. The research sample consists of
individual patients with one or more medical or disability
claims for at least one of eleven respiratory infection con-
dition. Resource utilization is contrasted with a 10 per-
cent random sample of the employer’s overall beneficiary
population. RESULTS: Direct (medical and pharmaceuti-
cal) and indirect (disability and sporadic absenteeism)
costs are analyzed. The average per capita annual costs
are: for the entire employer population, $2,368; for all
respiratory infections patients, $4,397; and for respira-
tory infections employees eligible for disability, $6,838.
Total costs for respiratory infections patients are 1.8
times those for the typical beneficiary. Total costs are
highest for patients with pneumonia ($11,544) and low-
est for patients with acute tonsillitis and acute pharyngi-
tis ($2,180). Medical and pharmaceutical treatment ac-
count for 65% of total costs for all respiratory infections
employees, while the remaining 35% of costs are attrib-
utable to disability and sporadic absenteeism. CONCLU-
SIONS: Respiratory infections impose a significant finan-
cial burden on the employer. Resource utilization by
respiratory infections patients is substantial, not only for
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the direct treatment of respiratory infections, but also for
the treatment of co-morbid medical conditions of respira-
tory infections patients. These costs also vary consider-
ably by type of respiratory infection. The study also
shows that respiratory infections impose substantial indi-
rect costs on employers from work loss associated with
these infections.
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OBJECTIVES: To examine the relationship between self-
reported health status, prophylactic medication utiliza-
tion, and health care service utilization in older adults
with asthma. METHODS: Design: A prospective longitu-
dinal cohort study was conducted over a 2-year post-
enrollment period in a population of managed care enrolled
asthmatic older adults. Patients completed a comprehen-
sive health risk screen at time of enrollment in the plan.
Setting: A Medicare HMO in the Southeastern United
States with prescription benefit. Participants: A total of
129 Medicare-HMO enrolled older adults with asthma
using inhaled corticosteroid therapy as prophylaxis were
available for complete follow up. Measurements: We
measured self-reported health perception, falls, lifestyle,
depressive symptomatology, and pre-enrollment health
care service use using a comprehensive risk screen. We
used the medication possession ratio and total annual
health care charges as measures of post-enrollment in-
haled corticosteroid and health care service use. RE-
SULTS: After adjusting for the effects of other variables
we found that depressive symptomatology (DS) at base-
line and increased comorbidity severity (using the Charl-
son comorbidity index) were associated with significant
reductions in prophylactic medication possession (27%
with DS, and 6% with unit increase in Charlson’s index,
p  0.05). Additionally we found, after adjusting for the
effects of baseline health status, a 10% increase in pro-
phylactic medication possession was associated with a
5% decrease in total annual health care charges in this
population (p  0.05). CONCLUSIONS: There seem to
be strong associations between poor health status at time
of enrollment, decreased post-enrollment prophylactic
medication use and increased post-enrollment health care
service utilization in older adults with asthma.
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OBJECTIVES: The purpose of this study is to adapt a
previously validated questionnaire to a pharmacy claims
database and examine its construct validity in measuring
severity of illness in chronic respiratory disease (CRD).
METHODS: The authors modified an asthma severity of
illness questionnaire (13 items, total score range 0–28)
based upon symptoms, medication use, hospitalization
information and intubation history to a scale that is more
conducive to retrospective data analysis. The adapted
CRD scale (CRDS) was based on pharmacy claims data
and hospitalization history (11 items, total score range 0–
18). The CRDS was compared to utility as measured by a
general health visual analogue scale and quality of life
(QoL) as measured by the Physical Component Scale
(PCS), Physical Function (PF) and General Health (GH)
domains of the SF-36. Panel data analysis was performed
on pharmacy claims and survey data from the Kaiser Per-
manente/USC Consultation Study. QoL and utility were
regressed on the CRDS, along with covariates. A non-res-
piratory chronic disease score was used to control for
chronic disease while avoiding significant multicollinear-
ity. The analysis was limited to 126 patients with CRD
followed over 3 years. The Hausman specification test
was used to determine the appropriateness of the ran-
dom-effects model formulation. RESULTS: The Haus-
man specification test suggested the use of the fixed-
effects formulation for utility (m  8.2, p  m  0.0420).
The CRDS was negative and significant (1.79, p 
0.0286). The Hausman test suggested a fixed-effects for-
mulation for PCS (p  m  0.0333) and random-effects
for GH (p  m  0.0628) and PF (p  m  0.1495). The
CRDS was significant and negative for all three QoL do-
mains: (PCS: 0.68, p  0.0085; PF: 0.97, p0.0130;
GH: 0.065, p  0.0077). CONCLUSION: The adapta-
tion of the asthma severity of illness questionnaire ap-
pears to be a valid measure of chronic respiratory disease
in a pharmacy claims database.
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OBJECTIVES: Adult patients with moderate to severe
asthma could potentially avoid utilizing excessive health
care resources by reducing the need for management of
severe adverse effects associated with albuterol. This
modeled analysis was performed from a managed care
payer perspective to determine if nebulized levalbuterol is
associated with a lower cost per decreased use of rescue
inhaler, as compared with nebulized racemic albuterol
over a four week period. METHODS: Cost data was ob-
tained from a public hospital, an HMO, and the Red
Book. Costs were measured in 2000 US dollars. Probabil-
ities were derived from a clinical controlled trial and the
National Center for Health Statistics. The primary out-
